Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Muscarinic acetylcholine receptor M1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | amine GPCR | Muscarinic acetylcholine receptor M1 | 460 aa | 463 aa | 27.0 % |
Echinococcus multilocularis | serotonin receptor | Muscarinic acetylcholine receptor M1 | 460 aa | 432 aa | 26.6 % |
Schistosoma japonicum | ko:K04136 adrenergic receptor, alpha 1b, putative | Muscarinic acetylcholine receptor M1 | 460 aa | 462 aa | 23.4 % |
Loa Loa (eye worm) | hypothetical protein | Muscarinic acetylcholine receptor M1 | 460 aa | 425 aa | 22.1 % |
Echinococcus granulosus | biogenic amine 5HT receptor | Muscarinic acetylcholine receptor M1 | 460 aa | 432 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0249 | 0.355 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0099 | 0.1304 | 0.0671 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0249 | 0.355 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0089 | 0.1143 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0089 | 0.1143 | 0.3218 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.1143 | 0.3218 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0089 | 0.1143 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0089 | 0.1143 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Brugia malayi | YY1-associated factor 2 | 0.0089 | 0.1143 | 0.3218 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0249 | 0.355 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0249 | 0.355 | 0.5 |
Onchocerca volvulus | 0.0099 | 0.1304 | 0.0671 | |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0089 | 0.1143 | 0.3218 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0089 | 0.1143 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0249 | 0.355 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0249 | 0.355 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0249 | 0.355 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0089 | 0.1143 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.1143 | 0.3218 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0089 | 0.1143 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0249 | 0.355 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.1143 | 0.3218 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0089 | 0.1143 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0089 | 0.1143 | 0.3218 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0249 | 0.355 | 0.2718 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0249 | 0.355 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0249 | 0.355 | 0.2718 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.1304 | 0.3673 |
Chlamydia trachomatis | SWIB complex protein | 0.0249 | 0.355 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0249 | 0.355 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.0249 | 0.355 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0089 | 0.1143 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0089 | 0.1143 | 0.3218 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.1143 | 0.3218 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0249 | 0.355 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.0249 | 0.355 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0089 | 0.1143 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0089 | 0.1143 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0249 | 0.355 | 0.2718 |
Brugia malayi | brahma associated protein 60 kDa | 0.0249 | 0.355 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0249 | 0.355 | 0.2718 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0249 | 0.355 | 0.2718 |
Plasmodium vivax | hypothetical protein, conserved | 0.0249 | 0.355 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.1143 | 0.3218 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0249 | 0.355 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0249 | 0.355 | 0.2718 |
Schistosoma mansoni | hypothetical protein | 0.0249 | 0.355 | 1 |
Onchocerca volvulus | 0.0249 | 0.355 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 10 uM | Allosteric modulation at rat M1 receptor expressed in CHO cells by calcium mobilization assay | ChEMBL. | 21194936 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.